tert-butyl 4-[6-[(6-bromo-8-cyclopentyl-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]pyridin-3-yl]piperazine-1-carboxylate
≥95%
- Product Code: 46745
CAS:
571188-82-4
| Molecular Weight: | 584.51 g./mol | Molecular Formula: | C₂₇H₃₄BrN₇O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2~8℃ |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry and drug development, particularly as an intermediate in the synthesis of kinase inhibitors. Kinase inhibitors are crucial in targeting specific enzymes involved in various cellular processes, making this compound valuable in the development of potential therapeutic agents for diseases such as cancer. Its structure, featuring a pyrido[2,3-d]pyrimidine core, allows it to interact effectively with kinase domains, enabling the design of molecules that can modulate signaling pathways. Researchers often employ this compound in preclinical studies to explore its efficacy and optimize its pharmacological properties for targeted therapies.
Product Specification:
| Test | Specification |
|---|---|
| Purity | 95 100% |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 5.000 | 10-20 days | €118.72 |
+
-
|
tert-butyl 4-[6-[(6-bromo-8-cyclopentyl-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]pyridin-3-yl]piperazine-1-carboxylate
This compound is primarily utilized in the field of medicinal chemistry and drug development, particularly as an intermediate in the synthesis of kinase inhibitors. Kinase inhibitors are crucial in targeting specific enzymes involved in various cellular processes, making this compound valuable in the development of potential therapeutic agents for diseases such as cancer. Its structure, featuring a pyrido[2,3-d]pyrimidine core, allows it to interact effectively with kinase domains, enabling the design of molecules that can modulate signaling pathways. Researchers often employ this compound in preclinical studies to explore its efficacy and optimize its pharmacological properties for targeted therapies.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
€0.00
€0.00
Total :